Abstract
Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 months. Evaluation by CMR using late gadolinium enhancement was notable for an absence of enhancement, suggesting an absence of irreversible myocyte injury and a good prognosis. CMR may be useful to predict recovery in toxin-associated non-ischemic cardiomyopathies.
| Original language | English (US) |
|---|---|
| Article number | 46 |
| Journal | Journal of Cardiovascular Magnetic Resonance |
| Volume | 11 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2009 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging
- Radiological and Ultrasound Technology
- Family Practice
- Medicine(all)
Cite this
Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance. / Lopez, Javier E; Yeo, Khung; Caputo, Gary R; Buonocore, Michael; Schaefer, Saul.
In: Journal of Cardiovascular Magnetic Resonance, Vol. 11, No. 1, 46, 2009.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance
AU - Lopez, Javier E
AU - Yeo, Khung
AU - Caputo, Gary R
AU - Buonocore, Michael
AU - Schaefer, Saul
PY - 2009
Y1 - 2009
N2 - Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 months. Evaluation by CMR using late gadolinium enhancement was notable for an absence of enhancement, suggesting an absence of irreversible myocyte injury and a good prognosis. CMR may be useful to predict recovery in toxin-associated non-ischemic cardiomyopathies.
AB - Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 months. Evaluation by CMR using late gadolinium enhancement was notable for an absence of enhancement, suggesting an absence of irreversible myocyte injury and a good prognosis. CMR may be useful to predict recovery in toxin-associated non-ischemic cardiomyopathies.
UR - http://www.scopus.com/inward/record.url?scp=74049134983&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=74049134983&partnerID=8YFLogxK
U2 - 10.1186/1532-429X-11-46
DO - 10.1186/1532-429X-11-46
M3 - Article
C2 - 19906310
AN - SCOPUS:74049134983
VL - 11
JO - Journal of Cardiovascular Magnetic Resonance
JF - Journal of Cardiovascular Magnetic Resonance
SN - 1097-6647
IS - 1
M1 - 46
ER -